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Specific Aim
BIOL 488
In order to improve the innate response in the immune system to recognize, 
elongate and increase anti-tumor responses in ovarian cancer patients, telomerase 
derived form (from)HeLa cells will be introduced into NK cells to increase their lifespan 
and efficacy in killing cancer cells associated with ovarian cancers.They will then be 
treated with a TK1- suicide gene in order to control NK cells activity. Pro-apoptotic 
activity will be measured to determine efficacy of treatment. 
HeLa cells will be obtained and murine NK cells will then be 
isolated from the spleen of rodents by way of monoclonal 
antibodies and magnetic separation.
Then the MANOVA model will be employed in order to log the 
volume of tumors that are observed
Bioluminescent Immaging will be utilized to observe pro-apoptotic 
activity in tumors treated with modified NK cells
NK cells that have been transfected with the TK1- suicide gene 
will be injected into the ID8 mouse ovarian model surface cells 
The NK cells will be transfected with both hTRT1 and hTRT2 to 
increase efficacy and  the inducted with HeLa derived 
telomerase  
Figure1. Bioluminescent imaging displaying tumor size before and after injection with tumor cells.
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• The modified NK cells made to improve efficacy in tumor destruction will in turn 
become cancerous.
• The telomerase that derived from HeLa cells failed to be successfully integrated 
within the NK cell, resulting in the lifespan of the cell remaining unchanged.
Figure 2.  Log scales containing the mean volume of tumors  at five different doses displayed on box plots .  Heitjan DF, Manni A, Santen RJ. Statistical analysis of in vivo tumor 
growth experiments. Cancer Res1993;53:6042–50.
• Through Bioluminescent Imagining, it is expected to observe a 
decrease in tumor size in mice treated with modified NK cells
• Through MANOVA analysis, pro-apoptotic activity is expected to 
show increase in mice treated with modified NK cells in comparison 
to mice that did not receive treatment with transformed cells
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• Ovarian Cancer is the fifth leading cause of cancer related death in women and affects around 22,000 women each year 
(American Cancer Society, 2018).
• Ovarian cancer is estimated to claim  13,980 lives in 2019 alone (American Cancer society, 2018).
• Survival rate is between 17%-39% due to prognosis occurring in the later stages of the disease
• NK ( Natural Killer) cells are the cells that ID as well as  kill tumor cells and are usually the first responders in these matters but 
short lived.
• Tumor cells have grown to be efficient in avoiding detection from innate immune cells
• NK cells will be given more time by taking telomerase from HeLa cells and placed in NK cells, increasing their efficiency in 
detecting, Identifying and killing tumor cells through increasing their lifespan
